MD4117C1 - Powder with haemostatic and regenerative properties (variants) and process for the production thereof - Google Patents
Powder with haemostatic and regenerative properties (variants) and process for the production thereof Download PDFInfo
- Publication number
- MD4117C1 MD4117C1 MDA20100113A MD20100113A MD4117C1 MD 4117 C1 MD4117 C1 MD 4117C1 MD A20100113 A MDA20100113 A MD A20100113A MD 20100113 A MD20100113 A MD 20100113A MD 4117 C1 MD4117 C1 MD 4117C1
- Authority
- MD
- Moldova
- Prior art keywords
- powder
- haemostatic
- production
- regenerative properties
- variants
- Prior art date
Links
- 239000000843 powder Substances 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 229940030225 antihemorrhagics Drugs 0.000 title abstract 2
- 230000000025 haemostatic effect Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000001172 regenerating effect Effects 0.000 title abstract 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 abstract 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 abstract 1
- 102000009123 Fibrin Human genes 0.000 abstract 1
- 108010073385 Fibrin Proteins 0.000 abstract 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229950003499 fibrin Drugs 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract 1
- 150000002829 nitrogen Chemical class 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
- NVBFHJWHLNUMCV-UHFFFAOYSA-N sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to medicine, in particular to a powder with haemostatic and regenerative properties, intended for the regeneration of teguments, especially those with hair and to a process for the production thereof.The powder, according to the invention, comprises fibrin or thrombin powder, anesthesin, anhydrous magnesium carbonate, lactose, sulfamide and colloidal silver powder coated with polyvinylpyrrolidone.The process, according to the invention, includes mixing of powder components, at the same time mixing with a colloidal silver powder coated with polyvinylpyrrolidone is carried out in a gravitational settling cyclone by spraying in a countercurrent, using as a carrier dehydrated nitrogen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20100113A MD4117C1 (en) | 2010-07-30 | 2010-07-30 | Powder with haemostatic and regenerative properties (variants) and process for the production thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20100113A MD4117C1 (en) | 2010-07-30 | 2010-07-30 | Powder with haemostatic and regenerative properties (variants) and process for the production thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD4117B1 MD4117B1 (en) | 2011-07-31 |
| MD4117C1 true MD4117C1 (en) | 2012-02-29 |
Family
ID=45815212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20100113A MD4117C1 (en) | 2010-07-30 | 2010-07-30 | Powder with haemostatic and regenerative properties (variants) and process for the production thereof |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD4117C1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4163C1 (en) * | 2010-12-23 | 2012-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Medicinal preparation in the form of gel for the prevention of postoperative complications |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8702349A1 (en) * | 1985-07-19 | 1987-01-01 | Bama Geve S A Lab | Silver sulphamide salt prepn. |
| FR2650275A1 (en) * | 1989-07-28 | 1991-02-01 | Shimi Ibrahim | New sulphamide derivatives, process for producing them and their application as medicaments |
| KR20060108034A (en) * | 2005-04-11 | 2006-10-17 | 주식회사 에이치오엔 | Antibacterial tableware with silver nano coating layer |
| CA2672134A1 (en) * | 2006-12-07 | 2008-06-19 | Daiichi Sankyo Company, Limited | Solid medicinal preparation containing mannitol or lactose |
| CN101229126A (en) * | 2008-01-23 | 2008-07-30 | 西北农林科技大学 | A kind of tinidazole composite nano-silver microemulsion antibacterial drug |
| WO2009013244A1 (en) * | 2007-07-21 | 2009-01-29 | Boehringer Ingelheim International Gmbh | Novel medicament in powder form comprising tiotropium and salmeterol, and lactose as excipient |
| RO122394B1 (en) * | 1998-05-15 | 2009-05-29 | Chaoying Zhao | Pharmaceutical compositions for emergency treatment and process for preparing the same |
| US20100150900A1 (en) * | 2008-12-12 | 2010-06-17 | Nicola Whitfield | Dry Powder Fibrin Sealant |
-
2010
- 2010-07-30 MD MDA20100113A patent/MD4117C1/en not_active IP Right Cessation
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES8702349A1 (en) * | 1985-07-19 | 1987-01-01 | Bama Geve S A Lab | Silver sulphamide salt prepn. |
| FR2650275A1 (en) * | 1989-07-28 | 1991-02-01 | Shimi Ibrahim | New sulphamide derivatives, process for producing them and their application as medicaments |
| RO122394B1 (en) * | 1998-05-15 | 2009-05-29 | Chaoying Zhao | Pharmaceutical compositions for emergency treatment and process for preparing the same |
| KR20060108034A (en) * | 2005-04-11 | 2006-10-17 | 주식회사 에이치오엔 | Antibacterial tableware with silver nano coating layer |
| CA2672134A1 (en) * | 2006-12-07 | 2008-06-19 | Daiichi Sankyo Company, Limited | Solid medicinal preparation containing mannitol or lactose |
| WO2009013244A1 (en) * | 2007-07-21 | 2009-01-29 | Boehringer Ingelheim International Gmbh | Novel medicament in powder form comprising tiotropium and salmeterol, and lactose as excipient |
| CN101229126A (en) * | 2008-01-23 | 2008-07-30 | 西北农林科技大学 | A kind of tinidazole composite nano-silver microemulsion antibacterial drug |
| US20100150900A1 (en) * | 2008-12-12 | 2010-06-17 | Nicola Whitfield | Dry Powder Fibrin Sealant |
Non-Patent Citations (2)
| Title |
|---|
| Fries D., Innerhofer P., Schobersberger W. Time for changing coagulation managment in trauma-related massive bleeding. Current Opinion in Anaesthesiology, 22(2), 2009, p. 267-274 * |
| Kılıç S, Timarkaan N. Unsaldı, Sveark. Comparison of Effects of Some Wound Healing Materials on Full Thickness Skin Wounds in Rabbits. Turkish Journal of Veterinary and Animal Sciences. 2002, 26, p.263-272 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4163C1 (en) * | 2010-12-23 | 2012-11-30 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Medicinal preparation in the form of gel for the prevention of postoperative complications |
Also Published As
| Publication number | Publication date |
|---|---|
| MD4117B1 (en) | 2011-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011138678A3 (en) | Compositions, gels and foams with rheology modulators and uses thereof | |
| TN2012000549A1 (en) | Substituted 5-fluoro-1h-pyrazolopyridines and use thereof | |
| MY162328A (en) | Catalyst systems and methods for using same to produce polyolefin products | |
| PH12013501143A1 (en) | Substituted 1-benzylcycloalkylcarboxlic acids and use thereof | |
| MX2013003309A (en) | Substituted benzamide compounds. | |
| ZA201601175B (en) | Regeneration of a titanium containing zeolite | |
| MX2012007922A (en) | Dry powder fibrin sealant. | |
| MX2011009369A (en) | Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators. | |
| MX2013012911A (en) | Alkylaminoalkyl oligomers as broad-spectrum antimicrobial agent. | |
| WO2015019198A3 (en) | High potency pancreatin pharmaceutical compositions | |
| GEP20135920B (en) | Kit for onychomycosis treatment | |
| MX2011008825A (en) | Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators. | |
| WO2010118291A3 (en) | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor | |
| AU2013288664B2 (en) | Dressing having the controlled release of active agents | |
| WO2013048692A3 (en) | Catalysts for producing acrylic acid and acrylates comprising vanadium, titanium and citric acid | |
| HK1202539A1 (en) | (r) -nifuratel, its use for the treatment of infections and synthesis of (r) and (s) -nifuratel | |
| HK1222325A1 (en) | High potency pancreatin pharmaceutical compositions | |
| MX2011008662A (en) | Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators. | |
| MX2011009338A (en) | Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators. | |
| IN2015DN03235A (en) | ||
| MX2012007392A (en) | Mixtures of alkali polysulfides. | |
| MD4117B1 (en) | Powder with haemostatic and regenerative properties (variants) and process for the production thereof | |
| MX2013002261A (en) | Substituted n-phenethyltriazoloneacetamides and use thereof. | |
| IL238931A0 (en) | Process for the preparation of (1s,4s,5s)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | |
| PH12013500219A1 (en) | Compounds with antibacterial activity against clostridium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG4A | Patent for invention issued | ||
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |